CIK 0001680367
- Non-accelerated filer
- Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812575858
- Phone
- +1 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- 4 Open-market sale Director sold 17,824 shares at an average $27.46 ($489,449)
- 4 Open-market sale Director sold 18,990 shares at an average $26.29 ($499,173)
- 4 Open-market sale Chief Executive Officer sold 10,545 shares at an average $25.36 ($267,392)
- 4 Open-market sale Director sold 16,592 shares at an average $25.24 ($418,809)
- 4 Open-market sale Chief Executive Officer sold 20,170 shares at an average $25.55 ($515,362)
- 4 Open-market sale Director sold 20,386 shares at an average $25.57 ($521,244)
- 4 Open-market sale General Counsel sold 4,000 shares at $26.25 ($104,982)
- 4 Open-market sale Chief Financial Officer sold 2,000 shares at $26.27 ($52,542)
- 4 Open-market sale Chief Executive Officer sold 27,072 shares at an average $26.13 ($707,494)
- 4 Open-market sale Director sold 27,521 shares at an average $26.12 ($718,855)
- 4 Other disposition Director disposed of 673,107 shares (other)
- 4 Option exercise Chief Financial Officer acquired 8,860 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 37,213 shares at an average $27.52 ($1,023,927)
- 4 Open-market sale Director sold 37,324 shares at an average $27.51 ($1,026,636)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $35.00 ($700,000)
- 4 Open-market sale General Counsel sold 5,000 shares at $35.00 ($175,000)
- 4 Open-market sale Chief Financial Officer sold 24,000 shares at $30.74 ($737,760)
- 4 Open-market sale General Counsel sold 7,000 shares at $30.77 ($215,390)
- 4 Option exercise Chief Medical Officer acquired 1,604 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 211 filings